KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Change in Cash (2016 - 2025)

Novartis Ag's Change in Cash history spans 15 years, with the latest figure at -$410.0 million for Q2 2025.

  • On a quarterly basis, Change in Cash rose 73.82% to -$410.0 million in Q2 2025 year-over-year; TTM through Jun 2025 was -$1.8 billion, a 83.2% increase, with the full-year FY2025 number at -$24.0 million, up 98.76% from a year prior.
  • Change in Cash hit -$410.0 million in Q2 2025 for Novartis Ag, up from -$5.5 billion in the prior quarter.
  • Over the last five years, Change in Cash for NVS hit a ceiling of $5.7 billion in Q3 2024 and a floor of -$10.2 billion in Q2 2022.
  • Historically, Change in Cash has averaged -$2.4 billion across 5 years, with a median of -$1.3 billion in 2023.
  • Biggest five-year swings in Change in Cash: plummeted 877.13% in 2022 and later soared 111.25% in 2023.
  • Tracing NVS's Change in Cash over 5 years: stood at -$4.5 billion in 2021, then crashed by 93.39% to -$8.8 billion in 2022, then soared by 111.25% to $988.0 million in 2023, then plummeted by 655.67% to -$5.5 billion in 2024, then surged by 92.53% to -$410.0 million in 2025.
  • Business Quant data shows Change in Cash for NVS at -$410.0 million in Q2 2025, -$5.5 billion in Q4 2024, and $5.7 billion in Q3 2024.